Skip to main content
logo
GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
83.19
+0.24 (0.29%)
Jul 24, 2025, 11:39 AM - Market open

Company Description

GeneDx Holdings Corp., a genomics company, provides genetic testing services.

It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.

The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.

The company is headquartered in Stamford, Connecticut.

GeneDx Holdings Corp.
GeneDx Holdings logo
CountryUnited States
Founded2017
IndustryDiagnostics & Research
SectorHealthcare
Employees1,000
CEOKatherine Stueland

Contact Details

Address:
North Tower, 6th Floor
Stamford, Connecticut 06902
United States
Phone888 729 1206
Websitegenedx.com

Stock Details

Ticker SymbolWGS
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001818331
CUSIP Number81663L200
ISIN NumberUS81663L2007
Employer ID85-1966622
SIC Code8000

Key Executives

NamePosition
Katherine A. StuelandPresident, Chief Executive Officer and Director
Kevin Feeley CPAChief Financial Officer
Dr. Bryan M. Dechairo Ph.D.Chief Operating Officer
Heidi C. Chen J.D.Chief Legal Officer
Jami BiliboacaHead of People Strategy
Melanie DuquetteChief Growth Officer
Dr. Martin G. Reese Ph.D.President of Fabric Genomics

Latest SEC Filings

DateTypeTitle
Jul 1, 2025144Filing
Jul 1, 2025144Filing
Jun 18, 20258-KCurrent Report
Jun 9, 2025144Filing
Jun 9, 2025144Filing
Jun 2, 2025144Filing
May 12, 2025SCHEDULE 13GFiling
May 9, 2025SCHEDULE 13G/AFiling
May 7, 2025SCHEDULE 13D/AFiling
Apr 30, 2025ARSFiling
View All SEC Filings